Printer Friendly

SCIMED RECEIVES FDA APPROVAL FOR TWO NEW PTCA ANGIOPLASTY PRODUCTS

 SCIMED RECEIVES FDA APPROVAL FOR TWO NEW PTCA ANGIOPLASTY PRODUCTS
 MINNEAPOLIS, Oct. 27, 1992 /PRNewswire/ -- SCIMED Life Systems, Incorporated (NASDAQ-NMS: SMLS) announced today that it has received FDA approval to market a new over-the-wire PTCA balloon catheter and its first PTCA guide wire product. These products will be shown at the American Heart Association's conference to be held in New Orleans, Nov. 16 to 19.
 Dale A. Spencer, president and chief executive officer, commented, "Although our general policy is not to comment on new products until they are officially launched, we felt that it was appropriate to announce these products due to previous comments we had made regarding the FDA approval rate."
 SCIMED Life Systems, Inc. develops, manufactures, and markets disposable medical devices, principally coronary and peripheral angioplasty catheters, for non-surgical treatment of cardiovascular disease. SCIMED's shares are traded on the NASDAQ National Market System under the symbol SMLS.
 -0- 10/27/92
 /CONTACT: Karen J. Kelsey, SCIMED director of investor and public relations, 612-494-1329/
 (SMLS) CO: SCIMED Life Systems, Inc. ST: Minnesota IN: MTC SU: PDT


KH -- MN010 -- 5227 10/27/92 09:25 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 27, 1992
Words:186
Previous Article:VANGUARD REPORTS RECORD 1992 THIRD QUARTER RESULTS
Next Article:CAGLE'S INC. REPORTS RESULTS
Topics:


Related Articles
ADVANCED INTERVENTIONAL SYSTEMS RECEIVES FDA PRE-MARKET APPROVAL
CORDIS' SLEUTH ANGIOPLASTY CATHETER GAINS MARKET APPROVAL
CORDIS' ORION SOFT TIP ANGIOPLASTY CATHETER GAINS MARKET APPROVAL
SCIMED ANNOUNCES INTRODUCTION OF HIGH-PERFORMANCE, NON-COMPLIANT PTCA BALLOON CATHETER AND ITS FIRST CORONARY GUIDE WIRE
SCIMED ANNOUNCES NEW PTCA GUIDE WIRE SYSTEM
CORDIS PREDATOR LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE
CORDIS GAINS FDA APPROVAL FOR FOUR NEW ANGIOPLASTY CATHETERS
SCIMED ENTERS U.S. DIAGNOSTIC CATHETER MARKET
LOCALMED RECEIVES THIRD FDA APPROVAL FOR CORONARY DRUG DELIVERY CATHETERS
Novoste Completes Patient Enrollment Into U.S. Feasibility Clinical Trial Of King Beta-Cath System for Reduction of Coronary Restenosis

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters